Chickenpox vaccine, also known as varicella vaccine, is a vaccine that protects against chickenpox.One dose of this vaccine prevents 100% of severe disease and 95% of moderate disease. Varicella vaccine is made up of Oka strain of live attenuated virus. This vaccine is safe and constitutes rare severe side effects. Moreover, varicella vaccine is 7090% effective in preventing varicella. We mainly focus on live attenuated varicella vaccine in this report.

The global Chickenpox Vaccine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Chickenpox Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Chickenpox Vaccine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Chickenpox Vaccine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Chickenpox Vaccine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Monovalent Vaccine
Combination Vaccine

Segment by Application
Kids Injection
Adults Injection